April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
December 7th 2023
A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
October 31st 2023
Check out these can't-miss Workflow Wednesdays sessions.
October 27th 2023
The awards recognize the teams, coaches, and pharmacies that have demonstrated outstanding commitment to transforming community pharmacy practice.
The CPESN Outstanding Network Facilitator Award is sponsored by Compliant Pharmacy Alliance.
CVS Caremark Sets Limits on Off-Label Treatments for COVID-19
CVS Caremark’s new quantity limits will not affect members who are already receiving these medications for their approved uses.
FDA OKs Crisaborole for Use in Children as Young as 3 Months of Age
Crisaborole ointment, 2% (Eucrisa, Pfizer) has been approved for use in pediatric patients with atopic dermatitis as young as 3 months of age.
Eli Lilly Offers Drive-Through COVID-19 Testing for Indianapolis Health Care Workers
The announcement follows their previous commitment to offering COVID-19 testing at local hospitals.
Growing Shortage of Albuterol Inhalers Due to COVID-19, ACAAI Advises
Due to the increased need for albuterol inhalers in hospitals for COVID-19, shortages have been occurring in some areas of the country and will likely continue to affect supplies.
FDA Approves Safety Labeling Changes to SGLT2 Inhibitors
The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.
FDA: No Scientific Evidence That NSAID Use Worsens COVID-19 Symptoms
There is currently no scientific evidence suggesting that non-steroidal anti-inflammatory drug use could worsen COVID-19 in those infected.
Preparing for Evolving Pharmacist Roles
What new gaps will pharmacists need to fill?
Addressing the ‘Glut’ of Pharmacists
It’s my hope that 2020 is a profession changing year, starting with the schools of pharmacy.
Phase 3 Trial to Evaluate Tocilizumab for Severe COVID-19 Pneumonia
Genentech is launching a phase 3 clinical trial evaluating tocilizumab (Actemra) plus standard of care for use in hospitalized adult patients with severe COVID-19 pneumonia.
COVID-19: What Community Pharmacies Are Doing in the Hardest-Hit States
Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.
CDC: Early Data Show Younger Adults Not Spared from Coronavirus Risks
A CDC analysis of preliminary data suggests that COVID-19 complications can occur in adults of any age.
NASH Drug Pipeline Shows Promise
Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.
Why Did You Become A Pharmacist?
We asked pharmacists from various settings around the country: “Why did you become a pharmacist, and what keeps you motivated?"
7 Pharmacist-Friendly Apps You Should Be Using
From drug information to patient education, these apps can help you be better at everything that you do.
Generic Ziprasidone Mesylate for Injection Now Available in United States
Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection.
COVID-19 May Remain Detectable on Surfaces, in Aerosols for Several Hours
A study evaluated the stability of COVID-19 compared with SARS-CoV-1.
Growing Your Business With Supplements
When looking to grow business with supplement sales, pharmacists should first educate themselves.
Prepare for Allergy Season
Relieving symptoms and optimizing therapies for allergic rhinitis
NCPA, NACDS Underscore Role of Community Pharmacists in Fighting COVID-19
President Trump's coronavirus task force urged to tap into the potential of community pharmacies in combatting the coronavirus pandemic.
Making A Career Pivot
Pharmacy managers and educators offer career advice.
Ubrogepant: A Novel Drug Mechanism for Migraine Treatment
On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.
Pharmacies Brace for Increased Refills Due to Coronavirus
Insurers, physicians, and others are advising patients with chronic conditions to ensure they have more than enough medication on hand.
Study Links Conscientious Vaccine Exemptions in Texas with Certain Demographics
A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.
FDA Grants Fast Track Designation to Empagliflozin for Chronic Kidney Disease
Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
What Pharmacists Should Know About Multiple Sclerosis
Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.
Pharmacy Chains, Other Retailers to Offer COVID-19 Testing
Walgreens, CVS Health, and Target said they will start providing coronavirus disease (COVID-19) testing in their parking lots.
Going Beyond Dispensing: The Future of Pharmacist Roles
Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.
New Study Examines Why Some Fare Better with the Flu Than Others
A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.
How To Turn Into A ‘Diabetes Pharmacy’
Creating a place where patients seek diabetes care and counseling.
Study Finds Habitual Fish Oil Use Linked to Cardiovascular Benefits
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.